Jennifer K. Moses

2020

In 2020, Jennifer K. Moses earned a total compensation of $1.7M as Chief Financial Officer at G1 Therapeutics, a 18% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$141,050
Option Awards$1,116,239
Salary$398,583
Other$8,550
Total$1,664,422

Moses received $1.1M in option awards, accounting for 67% of the total pay in 2020.

Moses also received $141.1K in non-equity incentive plan, $398.6K in salary and $8.6K in other compensation.

Rankings

In 2020, Jennifer K. Moses' compensation ranked 6,371st out of 13,090 executives tracked by ExecPay. In other words, Moses earned more than 51.3% of executives.

ClassificationRankingPercentile
All
6,371
out of 13,090
51st
Division
Manufacturing
2,627
out of 5,618
53rd
Major group
Chemicals And Allied Products
1,059
out of 2,251
53rd
Industry group
Drugs
915
out of 1,951
53rd
Industry
Pharmaceutical Preparations
683
out of 1,456
53rd
Source: SEC filing on April 28, 2021.

Moses' colleagues

We found five more compensation records of executives who worked with Jennifer K. Moses at G1 Therapeutics in 2020.

2020

Mark Velleca

G1 Therapeutics

Chief Executive Officer

2020

Soma Gupta

G1 Therapeutics

Chief Commercial Officer

2020

Mark Avagliano

G1 Therapeutics

Chief Business Officer

2020

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

2020

John Bailey

G1 Therapeutics

Chief Executive Officer

News

In-depth

You may also like